Bioequivalence of Flurbiprofen Lozenge vs Strepfen

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

July 15, 2018

Study Completion Date

July 15, 2018

Conditions
Healthy
Interventions
DRUG

Flurbiprofen Test 8.75 MG

Subjects will be asked to swallow saliva before dosing. For each administration, subjects will move the lozenge around in their mouth, suck on the lozenge continually for 15 min and swallow saliva at any time during the product administration procedures, being very careful not to swallow the lozenge.

DRUG

Flurbiprofen Reference 8.75 MG

Subjects will be asked to swallow saliva before dosing. For each administration, subjects will move the lozenge around in their mouth, suck on the lozenge continually for 15 min and swallow saliva at any time during the product administration procedures, being very careful not to swallow the lozenge.

Trial Locations (1)

CH-6864

CROSS Research S.A., Phase I Unit, Arzo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cross Research S.A.

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT04670601 - Bioequivalence of Flurbiprofen Lozenge vs Strepfen | Biotech Hunter | Biotech Hunter